Critical complications in cancer patients admitted to the ICU in the era of immunotherapy: recognition, differential diagnosis, and management - Top-Institutions - MDSpire

Life-Threatening Complications in Cancer Patients in the ICU During Immunotherapy: Identification, Differential Diagnosis, and Treatment Approaches

  • By

  • Di Wang

  • Min Yu

  • July 20, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Critical complications in cancer patients admitted to the ICU in the era of immunotherapy: recognition, differential diagnosis, and management

  • by Di Wang, Min Yu

  • July 20, 2026

Related Content

Late-phase strategies to overcome limitations of PD-1/PD-L1 therapy: a clinical development trajectory through 2030

Targeting stroma-mediated T-cell exclusion and functional exhaustion in pancreatic ductal adenocarcinoma through CXCR4 and PD-1 blockade

Cancer prevalence in the United States: trends and sociodemographic disparities based on national health interview survey data (2019–2023)